| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |